New test may better predict who will benefit from platelet transfusions
NCT ID NCT02858323
Summary
This study aimed to see if a newer lab test (C1q-binding) could better predict how well a patient will respond to a platelet transfusion compared to the standard test (IgG). Researchers analyzed stored blood samples from 68 patients with low platelet counts who had become resistant to standard platelet transfusions. The goal was to improve the matching process for future transfusions by understanding which test gives more useful information.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.